Chengdu Easton Biopharmaceuticals Co,Ltd
2 clinical trials · Sponsor
◉ Watch Chengdu Easton Biopharmaceuticals Co,Ltd
| Record | Firm | Date |
|---|---|---|
| a Safety and Tolerability Study of EP-9001A in Healthy Volunteers (NCT05278611) | Chengdu Easton Biopharmaceuticals Co,Ltd | 2022-03-23 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets (NCT05318326) | Chengdu Easton Biopharmaceuticals Co,Ltd | 2022-01-01 |
Track Chengdu Easton Biopharmaceuticals Co,Ltd automatically
Every clearance here is in the API, with alerts when new ones post.